Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 463  
CASE REPORT
Year : 2012  |  Volume : 11  |  Issue : 1  |  Page : 30-32

Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline


1 Department of Diagnostic Radiology, Khoo Teck Purt Hospital, Singapore
2 Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore

Correspondence Address:
Chjoong Howe Alvin Tan
Department of Diagnostic Radiology, Khoo Teck Puat Hospital, 90 Yishun Central, 768828
Singapore
Login to access the Email id


DOI: 10.4103/1450-1147.98745

Rights and Permissions

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a case where various molecular tracers (fluorodeoxyglucose, choline, and methoxyisobutylisonitrile) were used in the post-treatment assessment of a patient with histologically proven GBM.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3571    
    Printed163    
    Emailed0    
    PDF Downloaded368    
    Comments [Add]    
    Cited by others 4    

Recommend this journal